Pharmacokinetics and biological activity of atacicept in patients with rheumatoid arthritis. - Wikidata - awgldk - TriplyDB

Pharmacokinetics and biological activity of atacicept in patients with rheumatoid arthritis.

Pharmacokinetics and biological activity of atacicept in patients with rheumatoid arthritis.

http://www.wikidata.org/entity/Q40119794

about

Atacicept: targeting B cells in multiple sclerosis Immunotherapy of systemic sclerosis B-cell survival factors in autoimmune rheumatic disorders The rationale for BAFF inhibition in systemic lupus erythematosus Management of ANCA-associated vasculitis: Current trends and future prospects Clinical targeting of the TNF and TNFR superfamilies Pharmacokinetics, pharmacodynamics, short term efficacy and safety of RCT-18, a novel BLyS/APRIL fusion protein, in patients with rheumatoid arthritis.Synovial tissues concentrate secreted APRIL.Atacicept, a novel B cell-targeting biological therapy for the treatment of rheumatoid arthritis.The role of B cell depleting therapy in graft versus host disease after allogeneic hematopoietic cell transplant.Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.Targeting BAFF in autoimmunity.BAFF inhibition: a new class of drugs for the treatment of autoimmunity.Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis.Atacicept as an investigated therapy for rheumatoid arthritis.Pharmacokinetics, pharmacodynamics, and tolerability of single ascending doses of RCT-18 in Chinese patients with rheumatoid arthritis.Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: results of a phase II, randomized, placebo-controlled, dose-finding trial.Common Variable Immunodeficiency BC094916 suppressed SP 2/0 xenograft tumor by down-regulating Creb1 and Bcl2 transcription

P2860

Q24628925-03615FAE-709B-466B-8AAE-60E0B1D7D5C6 Q24634395-9E67BED4-5387-48B1-9DAE-79B9F02D2802 Q26796484-FE519760-ED7D-4348-B35D-F3BD448D247B Q26827373-30AA5349-DAF0-4B01-BAC7-0FC2512D1012 Q33947599-2F479BA4-7781-453E-BA6F-F65640F30FE2 Q36762882-63CF9FFC-5A04-4937-87D0-0E39290D5838 Q37030677-B51ED8FB-7020-49F4-A2A2-01127B82A3C1 Q37454022-C500847B-B0DF-498F-814C-A1D25D7309C9 Q37517575-0299424E-B3ED-4605-B05E-D0916079D963 Q37689179-70413568-5BDB-497C-AA1C-17CC23173C4B Q37716786-D07AD813-08BC-4A22-B1E3-AEE6F3D2169D Q37802627-2C2958B1-392C-446F-A40B-F2A140CC9CA0 Q37844764-0ADE90DB-B87B-4F97-BA10-5D2A40AFAB01 Q37968620-73C11A4F-CCD2-4260-B823-2184E2C6775B Q38235570-7F7C130D-BBCC-42EA-90F8-339A1666A517 Q41758222-8FB1E2E7-1F84-4ECD-8DA1-CC21C6F1F2DE Q46071397-7F1B3838-B4DC-4168-9438-0E54FE5B89A6 Q55982504-FFD52C3A-8FD5-46B3-88D5-BBC7197CFBFF Q58741742-9BAE0CD9-8954-41EA-9F9B-A2FE13C48B5B

P2860

Pharmacokinetics and biological activity of atacicept in patients with rheumatoid arthritis.

http://www.wikidata.org/entity/Q40119794

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Pharmacokinetics and biologica ...... nts with rheumatoid arthritis.

@en

type

label

Pharmacokinetics and biologica ...... nts with rheumatoid arthritis.

@en

prefLabel

Pharmacokinetics and biologica ...... nts with rheumatoid arthritis.

@en

P1433

Q40119794-828948AB-F8F9-48A3-B55A-54D66829AADE

P1476

Q40119794-F75AF7D2-A9A5-4E39-BE50-C4BB5D943C86

P2093

Q40119794-15B00204-40BB-4A78-82D9-E07702232B44

Q40119794-89A0DA65-C717-4054-90D3-2C1E5F74E4CF

Q40119794-AB49B2B6-66B8-4A50-9260-33F05ACFDAB9

Q40119794-D160D4D0-C3DA-4095-9FC7-88AA64A5C049

P2860

Q40119794-18CA405A-EA47-4FF8-8141-F18C73067F3C

Q40119794-19108654-B481-4B79-9D4B-16C76B72AF40

Q40119794-19D4358A-D8EE-4086-9BD8-D9D07ADB4542

Q40119794-1C1F88A2-BD43-4A15-925D-BD10E8F6F436

Q40119794-23061967-251B-4743-A37F-C86106EC8215

Q40119794-243C3936-E835-4FFF-8878-3B4BE0F265DF

Q40119794-275D2A30-2E13-452A-9EF4-7C4CE545FBA8

Q40119794-31F48FC0-0CAD-419F-AFC2-C3A6DA97C482

Q40119794-42F87AB9-E0C2-4AAE-A886-BB1B0CF60CC4

Q40119794-499616BE-5E06-45A2-B5A7-409A44EF2E41

P304

Q40119794-B87B814D-3188-41C3-80A6-E7B1F6BF5D8A

P31

Q40119794-5DEAB251-700B-4281-985B-EAA9B26F7EA7

P356

Q40119794-4629A0BC-EF3D-4CAB-B926-BE0BF3547739

P433

Q40119794-66E9A2D2-D159-419C-8812-65432473E371

P478

Q40119794-DC6C7836-9D1E-46BD-B718-EC9B22E5435A

P577

Q40119794-37E09D68-C006-4253-8D05-D78D0F42F034

P698

Q40119794-80854963-14B5-48DA-BFBA-AB4218039D71

P356

0091270008315312

P1433

The Journal of Clinical Pharmacology

P1476

Pharmacokinetics and biologica ...... nts with rheumatoid arthritis.

@en

P2093

Alain Munafo

http://www.w3.org/2001/XMLSchema#string

Ivan Nestorov

http://www.w3.org/2001/XMLSchema#string

Jennifer Visich

http://www.w3.org/2001/XMLSchema#string

Orestis Papasouliotis

http://www.w3.org/2001/XMLSchema#string

P2860

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed

NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily

Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI

BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases

BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF

BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses

Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus.

Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

P304

406-417

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0091270008315312

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18303125

http://www.w3.org/2001/XMLSchema#string